Literature DB >> 12234872

In vitro synergistic interaction between amphotericin B and pentamidine against Scedosporium prolificans.

Javier Afeltra1, Eric Dannaoui, Jacques F G M Meis, Juan L Rodriguez-Tudela, Paul E Verweij.   

Abstract

To develop new approaches for the treatment of invasive infections caused by Scedosporium prolificans, the in vitro interaction between amphotericin B and pentamidine against 30 clinical isolates was evaluated using a checkerboard microdilution method based on the National Committee for Clinical Laboratory Standards M38-P guidelines. The interaction between the drugs was analyzed using fractional inhibitory concentration index (FICI) analysis and response surface modeling. Amphotericin B alone was inactive against all the isolates. The geometric mean MIC for pentamidine was 57 micro g/ml (range, 8 to 256 micro g/ml; MIC at which 50% of the isolates tested were inhibited [MIC(50)], 64 micro g/ml; MIC(90), 128 micro g/ml). The combination was synergistic against 28 of 30 isolates (93.3%) by FICI analysis and 30 of 30 (100%) by response surface modeling analysis. Antagonism was not observed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12234872      PMCID: PMC128769          DOI: 10.1128/AAC.46.10.3323-3326.2002

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  27 in total

1.  In vitro antimicrobial activity of aromatic diamidines and diimidazolines related to pentamidine.

Authors:  I O Donkor; A M Clark
Journal:  Eur J Med Chem       Date:  1999 Jul-Aug       Impact factor: 6.514

2.  In vitro interaction of terbinafine with itraconazole against clinical isolates of Scedosporium prolificans.

Authors:  J Meletiadis; J W Mouton; J L Rodriguez-Tudela; J F Meis; P E Verweij
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

3.  In vitro activities of four novel triazoles against Scedosporium spp.

Authors:  A J Carrillo; J Guarro
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

4.  Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.

Authors:  M Cuenca-Estrella; B Ruiz-Díez; J V Martínez-Suárez; A Monzón; J L Rodríguez-Tudela
Journal:  J Antimicrob Chemother       Date:  1999-01       Impact factor: 5.790

5.  Potentiation of inhibition of wild-type and mutant human immunodeficiency virus type 1 reverse transcriptases by combinations of nonnucleoside inhibitors and d- and L-(beta)-dideoxynucleoside triphosphate analogs.

Authors:  G Maga; U Hübscher; M Pregnolato; D Ubiali; G Gosselin; S Spadari
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

6.  Comparison of fractional inhibitory concentration index with response surface modeling for characterization of in vitro interaction of antifungals against itraconazole-susceptible and -resistant Aspergillus fumigatus isolates.

Authors:  D T A Te Dorsthorst; P E Verweij; J F G M Meis; N C Punt; J W Mouton
Journal:  Antimicrob Agents Chemother       Date:  2002-03       Impact factor: 5.191

Review 7.  Disseminated infection and colonization by Scedosporium prolificans: a review of 18 cases, 1990-1999.

Authors:  P Idigoras; E Pérez-Trallero; L Piñeiro; J Larruskain; M C López-Lopategui; N Rodríguez; J M González
Journal:  Clin Infect Dis       Date:  2001-05-04       Impact factor: 9.079

8.  Use of a new bioassay to study pentamidine pharmacokinetics.

Authors:  E M Bernard; H J Donnelly; M P Maher; D Armstrong
Journal:  J Infect Dis       Date:  1985-10       Impact factor: 5.226

9.  In vitro activities of amphotericin B in combination with four antifungal agents and rifampin against Aspergillus spp.

Authors:  C E Hughes; C Harris; J A Moody; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

10.  Enhancement of the in vitro activity of amphotericin B against Aspergillus spp. by tetracycline analogs.

Authors:  C E Hughes; C Harris; L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

View more
  11 in total

Review 1.  Antifungal activity of nonantifungal drugs.

Authors:  J Afeltra; P E Verweij
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-06-26       Impact factor: 3.267

2.  Treatment options in emerging mold infections.

Authors:  Patricia Muñoz; Jesús Guinea; Emilio Bouza
Journal:  Curr Infect Dis Rep       Date:  2008-11       Impact factor: 3.725

3.  Caspofungin and liposomal amphotericin B therapy of experimental murine scedosporiosis.

Authors:  Rosie Bocanegra; Laura K Najvar; Steve Hernandez; Dora I McCarthy; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

Review 4.  Combination treatment of invasive fungal infections.

Authors:  Pranab K Mukherjee; Daniel J Sheehan; Christopher A Hitchcock; Mahmoud A Ghannoum
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

5.  Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis.

Authors:  Lisa Y Chiang; Daniele E Ejzykowicz; Zong-Qiang Tian; Leonard Katz; Scott G Filler
Journal:  Antimicrob Agents Chemother       Date:  2006-10       Impact factor: 5.191

Review 6.  Infections caused by Scedosporium spp.

Authors:  Karoll J Cortez; Emmanuel Roilides; Flavio Quiroz-Telles; Joseph Meletiadis; Charalampos Antachopoulos; Tena Knudsen; Wendy Buchanan; Jeffrey Milanovich; Deanna A Sutton; Annette Fothergill; Michael G Rinaldi; Yvonne R Shea; Theoklis Zaoutis; Shyam Kottilil; Thomas J Walsh
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

7.  Pentamidine is active in vitro against Fusarium species.

Authors:  Michail S Lionakis; Russell E Lewis; George Samonis; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

Review 8.  Scedosporium prolificans osteomyelitis in an immunocompetent child treated with voriconazole and caspofungin, as well as locally applied polyhexamethylene biguanide.

Authors:  William J Steinbach; Wiley A Schell; Jackie L Miller; John R Perfect
Journal:  J Clin Microbiol       Date:  2003-08       Impact factor: 5.948

9.  Bioactive Compounds Obtained from Polish "Marynka" Hop Variety Using Efficient Two-Step Supercritical Fluid Extraction and Comparison of Their Antibacterial, Cytotoxic, and Anti-Proliferative Activities In Vitro.

Authors:  Katarzyna Klimek; Katarzyna Tyśkiewicz; Malgorzata Miazga-Karska; Agnieszka Dębczak; Edward Rój; Grazyna Ginalska
Journal:  Molecules       Date:  2021-04-19       Impact factor: 4.411

Review 10.  Techniques for the Assessment of In Vitro and In Vivo Antifungal Combinations.

Authors:  Anne-Laure Bidaud; Patrick Schwarz; Guillaume Herbreteau; Eric Dannaoui
Journal:  J Fungi (Basel)       Date:  2021-02-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.